Affimed N.V. Shares Fall 1.3% Below Previous 52-Week Low - Market Mover
The shares fell 1.3% lower than its previous 52-week low of $4.78, with trading volume higher than its 30 day average
Jan 11, 2022 by Kwhen Finance Editors
Affimed N.V. (AFMD) shares closed 1.3% lower than its previous 52 week low, giving the company a market cap of $473M. The stock is currently down 12.7% year-to-date, down 22.0% over the past 12 months, and up 109.6% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%.
Trading Activity
- Trading volume this week was 54.0% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.5.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Affimed N.V. | -2.1 | -12.7 | -22.0 | -59.5 | -0.4 |
| Dow Jones Industrial Average | -0.4 | -0.3 | 18.5 | -2.3 | 22.9 |
| S&P 500 Index | -0.1 | -1.9 | 23.9 | -3.6 | 27.3 |
| Health Care | -0.0 | -5.2 | 13.2 | -6.3 | 20.4 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 51.4%
- The company's stock price performance over the past 12 months beats the peer average by -12.9%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Affimed N.V. | AFMD | 0 | -12.7 | -22.0 | -59.5 | -0.4 |
| Peer Avg | N/A | 75.0 | -8.4 | -25.3 | -56.8 | 12.6 |
| Repligen Corp. | RGEN | 96.2 | -21.9 | -0.8 | -37.9 | 25.2 |
| Agenus Inc | AGEN | 203.9 | -7.1 | -8.0 | -56.3 | 18.8 |
| Merrimack Pharmaceuticals Inc | MACK | 0 | -0.3 | -48.0 | -59.4 | 4.9 |
| Acorda Therapeutics Inc | ACOR | -0.1 | -4.2 | -44.3 | -73.7 | 1.3 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: